01 Integration of Social Determinants of Health into Clinical Risk Grouping Models The clinical risk grouping solution market analysis shows that healthcare organizations are incorporating social determinants of health into patient risk assessment. This encourages solution providers to combine clinical records with socioeconomic information, housing conditions, and healthcare access indicators to identify patients with complex care needs.
02 Development of Explainable AI Models for Clinical Risk Classification Explainable artificial intelligence (AI) is changing how clinical risk grouping solutions assess patients and present risk classification results. Explainable machine learning models highlight the clinical variables contributing to a patient's high-risk classification, supporting more informed care planning and population health management.
01 Supply chain disruptions are expected to have a moderate impact on the clinical risk grouping solution market share due to dependence on cloud infrastructure, data storage systems, and computing hardware. The market is likely to follow an S-shaped recovery, with gradual restoration of technology infrastructure and software implementation operations. Supply chain constraints could reduce market growth by 1.0–1.5 percentage points, lowering the projected CAGR of 12.78% to around 11.28%–11.78%. As supply conditions normalize, the clinical risk grouping solution market growth is expected to stabilize.
01 The clinical risk grouping solution market forecasts investment in AI-driven risk stratification and healthcare data integration.
02 Key Investment and Funding Activities in Clinical Risk Grouping SolutionMarket, 2026 Company Value (USD) Details Keebler Health USD 16 Million In April 2026, Keebler Health raised USD 16 million in Series A funding, led by Flare Capital Partners, bringing its total funding to USD 23 million. The company plans to expand commercial operations, staffing, and platform infrastructure for its AI-enabled risk adjustment solutions. Navina USD 55 Million In March 2026, Navina closed a USD 55 million Series C funding round, bringing its total funding to USD 100 million. Its AI-powered clinical intelligence platform supports risk adjustment, chart review, quality management, and analytics for healthcare providers and health plans.
01 Need to Predict Healthcare Costs Across Multimorbid Patient Populations and Severity-Based Risk Adjustment Drives Market Need to identify patients with high expected healthcare costs is strengthening demand for clinical risk grouping solutions. Healthcare providers and payers use diagnosis codes, medical claims, prior hospital admissions, and treatment histories to classify patients according to their expected resource utilization.Severity-based risk adjustment in Medicaid managed care increases the need for patient classification systems that account for differences in health status and treatment requirements. Wider use of risk-adjusted payment models strengthens demand for reliable patient-level risk classification and expenditure prediction.
01 Underreporting of Secondary Diagnoses and Limited Predictive Accuracy for Complex Multimorbidity Restrain Market Expansion Incomplete reporting of secondary diagnoses in insurance claims reduces the accuracy of clinical risk grouping and risk-adjustment models. Healthcare payers and providers require additional coding audits and data validation to improve the reliability of patient risk scores.Clinical risk grouping solutions can struggle to classify patients with multiple chronic conditions accurately when overlapping diagnoses, varying disease severity, and interactions between illnesses complicate risk assessment. Inaccurate classifications lead to underestimation of expected healthcare utilization and misallocation of care management resources.
01 Integration of Social Determinants of Health and Development of Condition-Specific Risk Grouping Models Offers Growth Opportunities Social determinants of health (SDOH) data offer opportunities for clinical risk grouping solution providers to incorporate housing instability, food insecurity, transportation barriers, and access to community services into patient risk assessments. Vendors offering risk grouping platforms integrated with social care and community referral data benefit from the expansion of value-based care programs.The need to distinguish healthcare utilization patterns across specific chronic diseases is creating opportunities for developers to build condition-specific risk grouping models for populations with diabetes, chronic kidney disease, heart failure, and multiple comorbidities. These models incorporate disease severity, treatment history, complications, and expected resource utilization to support more targeted patient stratification than broad demographic classifications alone.